Diagnostics-As-A-Service Market on Track for Strong Growth, Estimated to Grow at 20.8% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Diagnostics-As-A-Service Market Through 2025?
The market size of diagnostics-as-a-service has experienced remarkable growth over the past few years. The market is projected to expand from $4.45 billion in 2024 to $5.40 billion in 2025, representing a compound annual growth rate (CAGR) of 21.2%. This substantial growth during the historical period is due to factors such as the advent of digital healthcare, amplified demand for early disease identification, increasing acceptance of cloud-based solutions, the need for cost-efficient solutions in the face of rising healthcare expenses, and a heightened need for quicker and more precise diagnostics.

What's the Projected Size of the Global Diagnostics-As-A-Service Market by 2029?
The market for diagnostics-as-a-service is projected to experience a major surge in size over the coming years. It is forecasted to reach $11.50 billion in 2029, growing at a compound annual growth rate (CAGR) of 20.8%. Factors contributing to this forecasted growth are an increased prevalence of chronic illnesses, the expansion of personalized medicine, a growing need for remote and in-home testing, a strong focus on cost-effective diagnostics, and favorable efforts by regulatory bodies to promote digital health solutions. In this forecast period, significant trends to note include the utilization of AI in diagnostics, the application of cloud-based platforms, the integration of multi-omics solutions, in-home and remote testing, digital reporting integrated with real-time analytics, the assurance of data security through blockchain, and the rise of personalized, patient-oriented diagnostic services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diagnostics-as-a-service-global-market-report

Top Growth Drivers in the Diagnostics-As-A-Service Industry: What's Accelerating the Market?
Chronic diseases' rising incidence is projected to stimulate the diagnostics-as-a-service market's expansion. Chronic diseases are enduring health issues that progress gradually and persist for a long period, often necessitating consistent medical attention. Sedentary lifestyles partially contribute to these conditions, as extended sitting and limited physical activity increase the likelihood of ailments like heart disease and diabetes. Diagnostics-as-a-service facilitates chronic disease detection through cloud-based evaluations, simplifying the monitoring of ongoing conditions. The service enhances care by delivering prompt insights, lowering the frequency of hospital visits, and improving accessibility for patients with sustained health needs. For example, in June 2024, as per the National Health Service, a UK-based government agency, 3,615,330 individuals enrolled with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% surge from 3,065,825 instances in 2022. Therefore, the spiking incidence of chronic diseases is fuelling the growth of the diagnostics-as-a-service market. The burgeoning implementation of personalized medicine is projected to stimulate the diagnostics-as-a-service market's expansion. Personalized medicine is a healthcare approach that customizes prevention and treatment strategies based on a person's unique genetic composition, lifestyle, and environment. The rise in personalized medicine is primarily attributed to advancements in genomics, facilitating precise identification of genetic variances and individualized treatments. Diagnostics-as-a-service enhances personalized medicine by offering on-demand, cloud-based diagnostic solutions, enabling quick and accurate patient assessments. These services streamline data acquisition and evaluation, supporting customized treatment plans and enhancing clinical decision-making. For example, in February 2024, according to the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit organization, the U.S. Food and Drug Administration (FDA) authorized 26 new personalized treatments in 2023, a substantial increase from the 12 approved in 2022. Therefore, the rising implementation of personalized medicine is fuelling the growth of the diagnostics-as-a-service market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28193&type=smp

What Trends Will Shape the Diagnostics-As-A-Service Market Through 2029 and Beyond?
Leading firms in the diagnostics-as-a-service market are prioritizing the development of patient-oriented solutions, such as home lab testing services, to enhance access and comfort. Home lab testing services comprise diagnostic kits allowing individuals to gather samples at home and receive test outcomes without stepping foot into a clinic. To illustrate, in June 2025, US-based e-commerce firm Amazon India collaborated with Orange Health Labs, a health company based in India, to introduce Amazon Diagnostics, a home lab testing service within Amazon Medical. It can be accessed in six major cities, provides sample collection at the doorstep within one hour, and delivers digital reports in a minimum of six hours, spanning over 800 diagnostic examinations. The service, integrated into the Amazon app, enables customers to conveniently book, monitor, and securely access reports. With this initiative, Amazon addresses significant gaps in India's diagnostic field - delays, access, and quality - while bolstering its goal of offering comprehensive healthcare services, including pharmacies and clinics.

What Are the Main Segments in the Diagnostics-As-A-Service Market?
The diagnostics-as-a-service market covered in this report is segmented as

1) By Component: Software, Services, Platforms
2) By Deployment Mode: Cloud-Based, On-Premises, Hybrid
3) By Application: Clinical Diagnostics, Imaging Diagnostics, Pathology, Genomics, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users

Subsegments:
1) By Software: Diagnostic Analytics Software, Clinical Decision Support Software, artificial intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools, Imaging And Visualization Software, Data Integration And Interoperability Software, Remote Monitoring And Reporting Software
2) By Services: Diagnostic Testing Services, Remote And Virtual Diagnostic Services, Cloud-Based Data Storage And Management, Consulting And Implementation Services, Training And Support Services, Maintenance And Upgradation Services
3) By Platforms: Cloud-based Diagnostic Platforms, On-Premise Diagnostic Platforms, Hybrid Deployment Platforms, Application Programming Interface (API) And Integration Platforms, Mobile Or Tele-Diagnostics Platforms, Data Exchange And Collaboration Platforms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28193&type=smp

Which Top Companies are Driving Growth in the Diagnostics-As-A-Service Market?
Major companies operating in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc., and Probatix GmbH.

Which Regions Will Dominate the Diagnostics-As-A-Service Market Through 2029?
North America was the largest region in the diagnostics-as-a-service market in 2024. The regions covered in diagnostics-as-a-service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28193

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.